Inner Mongolia Furui Medical Science Co., Ltd. (300049) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Inner Mongolia Furui Medical Science Co., Ltd.

Why is Inner Mongolia Furui Medical Science Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 15.97% and Operating profit at 24.64% over the last 5 years

Flat results in Mar 26

INTEREST(HY) At CNY 1.88 MM has Grown at 21.58%
INTEREST COVERAGE RATIO(Q) Lowest at 7,560.79
DEBT-EQUITY RATIO (HY) Highest at -27.78 %

With ROE of 13.58%, it has a expensive valuation with a 4.67 Price to Book Value

Over the past year, while the stock has generated a return of 28.66%, its profits have risen by 56.3% ; the PEG ratio of the company is 0.6

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Inner Mongolia Furui Medical Science Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Inner Mongolia Furui Medical Science Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Inner Mongolia Furui Medical Science Co., Ltd.

24.22%

-0.38

62.97%

China Shanghai Composite

19.22%

1.46

13.80%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.97%

EBIT Growth (5y)

24.64%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.39

Sales to Capital Employed (avg)

0.77

Tax Ratio

27.81%

Dividend Payout Ratio

25.61%

Pledged Shares

Institutional Holding

ROCE (avg)

21.67%

ROE (avg)

9.89%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.67

EV to EBIT

21.93

EV to EBITDA

18.26

EV to Capital Employed

6.34

EV to Sales

5.31

PEG Ratio

0.61

Dividend Yield

ROCE (Latest)

28.92%

ROE (Latest)

13.58%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 369.76 MM

NET SALES(HY)

At CNY 854.49 MM has Grown at 22.15%

NET PROFIT(HY)

At CNY 75.16 MM has Grown at 88.28%

RAW MATERIAL COST(Y)

Fallen by -5.05% (YoY

CASH AND EQV(HY)

Highest at CNY 1,482.44 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 3.25 times

-12What is not working for the Company

INTEREST(HY)

At CNY 1.88 MM has Grown at 21.58%

INTEREST COVERAGE RATIO(Q)

Lowest at 7,560.79

DEBT-EQUITY RATIO (HY)

Highest at -27.78 %

OPERATING PROFIT(Q)

Lowest at CNY 68.87 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 19.12 %

Here's what is working for Inner Mongolia Furui Medical Science Co., Ltd.

Net Sales

At CNY 854.49 MM has Grown at 22.15%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Profit

At CNY 75.16 MM has Grown at 88.28%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Operating Cash Flow

Highest at CNY 369.76 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Cash and Eqv

Highest at CNY 1,482.44 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio

Highest at 3.25 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -5.05% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Inner Mongolia Furui Medical Science Co., Ltd.

Interest

At CNY 1.88 MM has Grown at 21.58%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 7,560.79

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit

Lowest at CNY 68.87 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 19.12 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debt-Equity Ratio

Highest at -27.78 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio